Cargando…

Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance

Risk assessment in newly diagnosed multiple myeloma patients (NDMM) is the first and the most crucial determinant of treatment. With the utilization of FISH analysis as a part of routine practice, high risk Multiple Myeloma (MM) is defined as having at least one of the mutations related with poor pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Baysal, Mehmet, Demirci, Ufuk, Umit, Elif, Kirkizlar, Hakki Onur, Atli, Emine Ikbal, Gurkan, Hakan, Gulsaran, Sedanur Karaman, Bas, Volkan, Mail, Cisem, Demir, Ahmet Muzaffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136246/
https://www.ncbi.nlm.nih.gov/pubmed/32249811
http://dx.doi.org/10.1038/s41598-020-62885-0
_version_ 1783518208470286336
author Baysal, Mehmet
Demirci, Ufuk
Umit, Elif
Kirkizlar, Hakki Onur
Atli, Emine Ikbal
Gurkan, Hakan
Gulsaran, Sedanur Karaman
Bas, Volkan
Mail, Cisem
Demir, Ahmet Muzaffer
author_facet Baysal, Mehmet
Demirci, Ufuk
Umit, Elif
Kirkizlar, Hakki Onur
Atli, Emine Ikbal
Gurkan, Hakan
Gulsaran, Sedanur Karaman
Bas, Volkan
Mail, Cisem
Demir, Ahmet Muzaffer
author_sort Baysal, Mehmet
collection PubMed
description Risk assessment in newly diagnosed multiple myeloma patients (NDMM) is the first and the most crucial determinant of treatment. With the utilization of FISH analysis as a part of routine practice, high risk Multiple Myeloma (MM) is defined as having at least one of the mutations related with poor prognosis including; t(4;14) t(14;16), t(14;20), del 17p, p53 mutation, gain 1q and del 1p. M-Smart MM risk stratification guideline by Mayo Clinic has proposed a concept similar to high grade lymphomas. Having two of the high risk genetic abnormalities were defined as double hit MM and having any three as triple hit MM. Based on these definitions which may bring a much more clinically relatable understanding in MM prognosis, we aimed to assess our database regarding these two concepts and their probable significance in terms of outcome and prognosis. We retrospectively evaluated 159 newly diagnosed multiple myeloma patients and their clinical course. Among these patients; twenty-four patients have one high risk determinant and also seven and two patients were classified as double hit MM and triple hit MM respectively. Overall survival (OS) of the patients with double hit MM was 6 months, 32.0 months for patients with single high risk abnormality and 57.0 months for patients with no high risk abnormality. Univariate analysis showed that Double Hit and Triple Hit MM is a predictive of low OS. Hazard Ratio of patients with one high risk abnormality was 1.42, double-hit MM patients was 5.55, and triple-hit MM patients was 7.3. Despite the development of novel drugs and their effects of prolonging survival, the treatment has not been individualized. Understanding the biology of each patient as a unique process will be the success of the treatment. As it is known that some MM patients harbor high risk genetic abnormalities according to FISH analysis, we can continue the argument that some patients bring an even higher risk and that can be defined as double or triple hit MM.
format Online
Article
Text
id pubmed-7136246
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71362462020-04-11 Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance Baysal, Mehmet Demirci, Ufuk Umit, Elif Kirkizlar, Hakki Onur Atli, Emine Ikbal Gurkan, Hakan Gulsaran, Sedanur Karaman Bas, Volkan Mail, Cisem Demir, Ahmet Muzaffer Sci Rep Article Risk assessment in newly diagnosed multiple myeloma patients (NDMM) is the first and the most crucial determinant of treatment. With the utilization of FISH analysis as a part of routine practice, high risk Multiple Myeloma (MM) is defined as having at least one of the mutations related with poor prognosis including; t(4;14) t(14;16), t(14;20), del 17p, p53 mutation, gain 1q and del 1p. M-Smart MM risk stratification guideline by Mayo Clinic has proposed a concept similar to high grade lymphomas. Having two of the high risk genetic abnormalities were defined as double hit MM and having any three as triple hit MM. Based on these definitions which may bring a much more clinically relatable understanding in MM prognosis, we aimed to assess our database regarding these two concepts and their probable significance in terms of outcome and prognosis. We retrospectively evaluated 159 newly diagnosed multiple myeloma patients and their clinical course. Among these patients; twenty-four patients have one high risk determinant and also seven and two patients were classified as double hit MM and triple hit MM respectively. Overall survival (OS) of the patients with double hit MM was 6 months, 32.0 months for patients with single high risk abnormality and 57.0 months for patients with no high risk abnormality. Univariate analysis showed that Double Hit and Triple Hit MM is a predictive of low OS. Hazard Ratio of patients with one high risk abnormality was 1.42, double-hit MM patients was 5.55, and triple-hit MM patients was 7.3. Despite the development of novel drugs and their effects of prolonging survival, the treatment has not been individualized. Understanding the biology of each patient as a unique process will be the success of the treatment. As it is known that some MM patients harbor high risk genetic abnormalities according to FISH analysis, we can continue the argument that some patients bring an even higher risk and that can be defined as double or triple hit MM. Nature Publishing Group UK 2020-04-06 /pmc/articles/PMC7136246/ /pubmed/32249811 http://dx.doi.org/10.1038/s41598-020-62885-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Baysal, Mehmet
Demirci, Ufuk
Umit, Elif
Kirkizlar, Hakki Onur
Atli, Emine Ikbal
Gurkan, Hakan
Gulsaran, Sedanur Karaman
Bas, Volkan
Mail, Cisem
Demir, Ahmet Muzaffer
Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
title Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
title_full Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
title_fullStr Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
title_full_unstemmed Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
title_short Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
title_sort concepts of double hit and triple hit disease in multiple myeloma, entity and prognostic significance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136246/
https://www.ncbi.nlm.nih.gov/pubmed/32249811
http://dx.doi.org/10.1038/s41598-020-62885-0
work_keys_str_mv AT baysalmehmet conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT demirciufuk conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT umitelif conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT kirkizlarhakkionur conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT atliemineikbal conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT gurkanhakan conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT gulsaransedanurkaraman conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT basvolkan conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT mailcisem conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance
AT demirahmetmuzaffer conceptsofdoublehitandtriplehitdiseaseinmultiplemyelomaentityandprognosticsignificance